Rotary Magnetic field can be generated by a spinning magnet or magnets. Or it can be implemented with 2 or more coils, power with a phase shift between them (90 deg for 2 coil implementation) (60deg for 3 coil implementation)
Targets affected are mostly the same as for Magnet fields
Main differences
- may enhance the EPR effect allowing targeting of drugs to cancer cells
- acts as wireless stirrer, especially on magnetic particles(inducing eddy currents in water media)
- research for use in nano surgery, and mechanical destruction of cancer cells
- continue to highlight ability to raise ROS in cancer cell and lower ROS in normal cells
- RMF may be responsible for Ca2+ distribution to pass across the plasma membrane(differental affected for cancer and normal cells)
Pathways:
- induce
ROS production in cancer cells,
while decreasing ROS in normal cells. Ca2+ is critical and the Ca2+ balance is increased in cancer
cells while decreased in normal cells (example for wound healing)
- ROS↑ related:
MMP↓(ΔΨm),
Ca+2↑,
Cyt‑c↑,
Caspases↑,
DNA damage↑,
cl-PARP↑,
HSP↓,
Prx,
- Raises
AntiOxidant
defense in Normal Cells:
OS↓">ROS↓,
NRF2↑,
SOD↑,
GSH↑,
Catalase↑,
- lowers
Inflammation :
NF-kB↓,
COX2↓,
p38↓, Pro-Inflammatory Cytokines :
TNF-α↓,
IL-6↓,
- inhibit Growth/Metastases :
TumMeta↓,
TumCG↓,
MMPs↓,
MMP2↓,
MMP9↓,
IGF-1↓,
RhoA↓,
NF-κB↓,
TGF-β↓,
ERK↓
- cause Cell cycle arrest :
TumCCA↑,
- inhibits Migration/Invasion :
TumCMig↓,
TumCI↓,
TNF-α↓,
ERK↓,
- Others: PI3K↓,
AKT↓,
Wnt↓,
AMPK,
ERK↓,
JNK,
- Synergies:
<
Others(review target notes),
Neuroprotective,
Cognitive,
- Selectivity:
Cancer Cells vs Normal Cells
Rotating Magnetic Fields
| Rank |
Pathway / Axis |
Cancer Cells |
Normal Cells |
TSF |
Primary Effect |
Notes / Interpretation |
| 1 |
ROS (tumor-selective oxidative stress) |
↑ ROS (P→R); sustained to cytotoxicity (G) |
↔ minimal change or transient ↑ without injury (P→R) |
P, R, G |
Primary stress amplifier |
Oncomagnetic reports emphasize selective tumor ROS increase with normal-cell sparing in comparable exposure conditions |
| 2 |
Mitochondrial ETC inhibition (Complex I/NADH:ubiquinone) |
↓ Complex I / respiration (P→R) |
↔ limited effect (P→R) |
P, R |
Bioenergetic collapse trigger |
Rotating/spinning fields are proposed to disrupt mitochondrial electron flow, driving ROS elevation upstream of ΔΨm loss |
| 3 |
Ca²⁺ signaling (ER–mitochondria Ca²⁺ transfer / mitochondrial Ca²⁺ load) |
↑ Ca²⁺ dysregulation (P→R) contributing to mitochondrial failure (G) |
↔ buffered Ca²⁺ homeostasis (P→R) |
P, R, G |
Amplifies ETC/ROS-driven toxicity |
RMF-driven mitochondrial stress can propagate via Ca²⁺ transfer to accelerate ΔΨm loss and pro-death ER stress in tumor cells while sparing normal cells |
| 4 |
Mitochondrial permeability transition pore (MPTP) |
↑ sustained MPTP opening (R→G) |
↔ resistant to opening |
P, R, G |
Mitochondrial point-of-no-return |
RMF-enhanced ROS and Ca²⁺ loading promote persistent MPTP opening in tumor mitochondria, driving energetic collapse and apoptosis while normal cells remain below the opening threshold |
| 5 |
ΔΨm / mitochondrial membrane integrity |
↓ ΔΨm (R); progresses (G) |
↔ preserved |
R, G |
Mitochondrial failure threshold |
Matches the “energy factory” targeting concept described in Oncomagnetic mechanism narratives |
| 6 |
GSH depletion |
↓ GSH (R→G) |
↔ maintained |
R, G |
Loss of redox buffering |
Cancer-selective inability to restore GSH is a key discriminator vs normal cells |
| 7 |
NRF2 response (selectivity gate) |
↔ delayed/insufficient NRF2 (R→G) |
↑ NRF2 (R→G) |
R, G |
Adaptive protection |
Normal-cell sparing is consistent with competent NRF2-driven antioxidant defense |
| 8 |
ER stress / UPR (CHOP commitment) |
↑ ER stress (R); CHOP/apoptotic UPR (G) |
↑ adaptive UPR (R); resolves (G) |
R, G |
Proteostasis failure |
ETC/ROS stress propagates to ER; commitment vs resolution diverges by cell robustness |
| 9 |
DNA damage (oxidative; checkpoint markers) |
↑ DNA damage (R→G) |
↔ or repaired (G) |
R, G |
Checkpoint stress |
Interpreted as ROS-mediated consequence; reported as increased damage markers in some translational datasets |
| 10 |
LDH / glycolytic vulnerability |
↓ LDH performance / ↓ glycolytic flux (R→G) |
↔ metabolic flexibility |
R, G |
Metabolic choke |
Cancer glycolysis becomes unstable when NADH/NAD+ and redox buffering are stressed |
| 11 |
TrxR / thioredoxin system overload |
↓ reserve (R→G) |
↔ preserved |
R, G |
Parallel antioxidant collapse |
Useful when GSH data are mixed; TrxR can be the limiting system under sustained ROS |
Time-Scale Flag: TSF = P / R / G
P: 0–30 min (physical / electron / radical effects)
R: 30 min–3 hr (redox signaling & stress response)
G: >3 hr (gene-regulatory adaptation)
MPTP: opening represents a mitochondrial commitment event integrating ROS and Ca²⁺ stress; sustained opening indicates irreversible bioenergetic failure.
|